An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

AI is increasingly being adopted across healthcare and in 2025, it will be a driving force behind a smarter, nimbler, and ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...